Boulder, CO, United States of America

Samuel Kintz

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):

Title: Samuel Kintz: Innovator in Cancer Treatment

Introduction

Samuel Kintz is a notable inventor based in Boulder, Colorado, recognized for his contributions to the field of cancer treatment. He holds a total of four patents, showcasing his innovative approach to medical science.

Latest Patents

Kintz's latest patents focus on 5- and 6-azaindole compounds for the inhibition of Bcr-Abl tyrosine kinases. These compounds and compositions are designed to inhibit Bcr-Abl tyrosine kinases, which play a crucial role in the development of various cancers, including chronic myeloid leukemia (CML). The methods of preparing these compounds and their applications in cancer treatment highlight Kintz's commitment to advancing medical research.

Career Highlights

Throughout his career, Kintz has worked with several companies, including Enliven, Inc. and Enliven Therapeutics, Inc. His work in these organizations has contributed significantly to the development of innovative therapies aimed at treating cancer.

Collaborations

Kintz has collaborated with various professionals in his field, including his coworker Li Ren. These collaborations have further enhanced his research and development efforts.

Conclusion

Samuel Kintz's work in the field of cancer treatment through his innovative patents demonstrates his dedication to improving patient outcomes. His contributions continue to influence the medical community and inspire future research in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…